JMPWA
VYNT

JP Morgan Private Wealth Advisors’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-8,202
Closed -$55K – 2100
2021
Q4 		$55K Hold
8,202
– – ﹤0.01% 1958
2021
Q3 		$96K Hold
8,202
– – ﹤0.01% 1904
2021
Q2 		$153K Buy
+8,202
New +$153K ﹤0.01% 1855

Other funds holding VYNT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FWM
Frontier Wealth Management Kansas City, Missouri $1.38B AUM 6.3% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
JSC
Jackson Square Capital San Francisco, California $719M AUM 144.18% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return

JP Morgan Private Wealth Advisors's VYNT Position: Q1 2022 in Review

JP Morgan Private Wealth Advisors sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q1 2022, closing a stake of 8,202 shares — an estimated $55K sold.

JP Morgan Private Wealth Advisors first reported a position in VYNT in Q2 2021 and held it in 3 quarters. The position peaked at $153K in Q2 2021. 23 funds tracked by Wall St. Rank hold VYNT as of Q1 2022.

  • JP Morgan Private Wealth Advisors reported no remaining Vyant Bio, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 8,202 Vyant Bio, Inc. Common Stock shares in Q1 2022, an estimated $55K.
  • JP Morgan Private Wealth Advisors first reported a position in Vyant Bio, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • JP Morgan Private Wealth Advisors's Vyant Bio, Inc. Common Stock position peaked at $153K in Q2 2021.
  • 23 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q1 2022.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q1 2022, filed 16 May 2022.